(S)-Flurbiprofen
- Product Name
- (S)-Flurbiprofen
- CAS No.
- 51543-39-6
- Chemical Name
- (S)-Flurbiprofen
- Synonyms
- CS-1959;C1sH13FO2;d-Flurbiprofen;Esflurbiprofen;Dexflurbiprofen;(S)-FLURBIPROFEN;(+)-Flurbiprofen;(S)-2-Flurbiprofen;(S)-(+)-FLURBIPROFEN;Flurbiprofen (S)-Isomer
- CBNumber
- CB8284910
- Molecular Formula
- C15H13FO2
- Formula Weight
- 244.26
- MOL File
- 51543-39-6.mol
(S)-Flurbiprofen Property
- Melting point:
- 109-110 °C(lit.)
- Boiling point:
- 376.2±30.0 °C(Predicted)
- Density
- 1.199±0.06 g/cm3(Predicted)
- storage temp.
- Sealed in dry,Room Temperature
- solubility
- insoluble in H2O; ≥10.9 mg/mL in DMSO; ≥69.1 mg/mL in EtOH
- form
- A crystalline solid
- pka
- 4.14±0.10(Predicted)
- color
- White to off-white
Safety
- Hazard Codes
- T
- Risk Statements
- 25
- Safety Statements
- 36/37/39-45
- RIDADR
- UN 2811 6.1/PG 3
- WGK Germany
- 3
Hazard and Precautionary Statements (GHS)
- Symbol(GHS)
-
- Signal word
- Danger
- Hazard statements
-
H301Toxic if swalloed
- Precautionary statements
-
P264Wash hands thoroughly after handling.
P264Wash skin thouroughly after handling.
P270Do not eat, drink or smoke when using this product.
P405Store locked up.
P501Dispose of contents/container to..…
N-Bromosuccinimide Price
- Product number
- 10004207
- Product name
- (S)-Flurbiprofen
- Purity
- ≥99%
- Packaging
- 100mg
- Price
- $97
- Updated
- 2024/03/01
- Product number
- 10004207
- Product name
- (S)-Flurbiprofen
- Purity
- ≥99%
- Packaging
- 250mg
- Price
- $231
- Updated
- 2024/03/01
- Product number
- 10004207
- Product name
- (S)-Flurbiprofen
- Purity
- ≥99%
- Packaging
- 500mg
- Price
- $437
- Updated
- 2024/03/01
- Product number
- 10004207
- Product name
- (S)-Flurbiprofen
- Purity
- ≥99%
- Packaging
- 1g
- Price
- $776
- Updated
- 2024/03/01
- Product number
- F598735
- Product name
- (S)-Flurbiprofen
- Packaging
- 5g
- Price
- $1130
- Updated
- 2021/12/16
(S)-Flurbiprofen Chemical Properties,Usage,Production
Description
Marketed by Taisho Pharmaceutical Holdings Co., Ltd., and Teijin Pharma Ltd., the (S)-enantiomer of flurbiprofen (named Esflurbiprofen) was approved as a new drug by the PMDA of Japan in 2015. (S)- Flurbiprofen, a cyclooxygenase (COX)-inhibiting nonsteroidal anti-inflammatory (NSAID) drug, is formulated with mentha oil and administered by way of a patch as a treatment for osteoarthritis in the current invention. Interestingly, the (R)- enantiomer is responsible for minimal COX inhibition but has been implicated as a possible treatment for a variety of other diseases. Synthetic approaches to racemic flurbiprofen have been reported in the chemical literature as early as the 1960s, and the mixture was approved as a drug in the United States by the FDA in 1988, marketed by Pharmacia and Upjohn. Toward this end, the current patent estate defines the utility of the active S-enantiomer, and synthetic approaches therein apply to this enantiomer only.
Description
(S)-Flurbiprofen is the COX-active enantiomer of the non-selective COX inhibitor flurbiprofen with IC50 values of 0.48 and 0.47 μM for COX-1 and COX-2, respectively, in guinea pig whole blood. It inhibits the release of 6-keto prostaglandin F1α (6-keto-PGF1α; ) and thromboxane B2 (TXB2; ) from rat whole blood, gastric mucosa, lung, and jejunal tissue ex vivo in a dose-dependent manner. (S)-Flurbiprofen (1 nM) inhibits basal and bradykinin-, serotonin-, and histamine-stimulated prostaglandin E2 (PGE2) release from isolated skin flaps of rat lower hind paws. It also inhibits release of the neuroinflammatory marker calcitonin gene-related peptide (CGRP; Item Nos. 24405 | 24725 | 24728) when used at a concentration of 1 μM. In vivo, (S)-flurbiprofen reduces the number of flinches per minute in the formalin test in rats, indicating antinociceptive activity.
Uses
(S)-Flurbiprofen is the S-isomer of Flurbiprofen (F598700), an anti-inflammatory used as an analgesic.
Definition
ChEBI: (S)-flurbiprofen is a flurbiprofen. It is an enantiomer of a (R)-flurbiprofen.
Synthesis
The synthesis began with conversion of commercially available aniline 168 to racemic flurbiprofen (169) through a Sandmeyer reaction and subsequent phenyl group introduction through the use of sodium tetraphenylborate. A chiral resolution was then performed on the resulting stereogenic acid on multikilogram scale by treatment with (S)- 1-phenylethylamine in MeOH/toluene, which gave various yields of salt 170 as reported by the authors. Acidification with aqueous HCl delivered (S)-flurbiprofen (XXI). Importantly, with respect to green chemistry considerations, the (R)- enantiomer could be recycled by racemizing the undesired (R)- enantiomer 171 in refluxing methanolic sulfuric acid, improving the overall atom economy of the process and significantly reducing waste.
in vitro
it was found that the ic50 value of (s)-flurbiprofen was about 0.5 μm for both cox-1 and cox-2 in guinea pig whole blood [1].
in vivo
the efficacy of multiple applications of s(+)-flurbiprofen plaster (sfpp) was evaluated for the alleviation of inflammatory pain and edema in rat adjuvant-induced arthritis model. multiple applications of sfpp could exert a significant analgesic effect from the first day of application as compared to the other nsaid drugs. in terms of paw edema, sfpp could decrease edema from the second day after application. moreover, multiple applications of sfpp were found to be superior to those of other nsaid drugs in terms of the analgesic effect [2].
IC 50
0.5 μm for both cox-1 and cox-2 in guinea pig whole blood
References
[1] barnett, j. ,chow, j.,ives, d., et al. purification, characterization and selective inhibition of human prostaglandin g/h synthase 1 and 2 expressed in the baculovirus system. biochimica et biophysica acta 1209, 130-139 (1994).
[2] sugimoto m et al. topical anti-inflammatory and analgesic effects of multiple applications of s(+)-flurbiprofen plaster (sfpp) in a rat adjuvant-induced arthritis model. drug dev res. 2016 jun;77(4):206-11.
[3] yataba i, otsuka n, matsushita i, matsumoto h, hoshino y. the efficacy and safety of s-flurbiprofen plaster in the treatment of knee osteoarthritis: a phase ii, randomized, double-blind, placebo-controlled, dose-finding study. j pain res. 2017 apr 11;10:867-880.
(S)-Flurbiprofen Preparation Products And Raw materials
Raw materials
Preparation Products
(S)-Flurbiprofen Suppliers
- Tel
- +86-0838-2319818 +86-15982001943
- seniorpharma@163.com
- Country
- China
- ProdList
- 420
- Advantage
- 55
- Tel
- 029-81310890 13571859809
- info@pushanshiye.com
- Country
- China
- ProdList
- 10005
- Advantage
- 58
- Tel
- 0632-0632-2980981 15063270987
- Fax
- 0632-2989678
- service.china3@viwit.com
- Country
- China
- ProdList
- 135
- Advantage
- 55
- Tel
- 18072995930
- sales001@hongdabova.com
- Country
- China
- ProdList
- 24
- Advantage
- 58
- Tel
- 0592-5789919 13328776692
- 2851802016@qq.com
- Country
- China
- ProdList
- 80
- Advantage
- 58
- Tel
- 010-82848833 400-666-7788
- Fax
- 86-10-82849933
- jkinfo@jkchemical.com
- Country
- China
- ProdList
- 94657
- Advantage
- 76
- Tel
- 025-83697070
- Fax
- +86-25-83453306
- info@chemlin.com.cn
- Country
- China
- ProdList
- 19172
- Advantage
- 64
- Tel
- 400 638 7771
- sales@heowns.com
- Country
- China
- ProdList
- 14435
- Advantage
- 57
- Tel
- +86 (573) 82222445 (0)18006601000 452520369
- Fax
- +86 (573) 82222643
- sales@maya-r.com
- Country
- China
- ProdList
- 11707
- Advantage
- 57
- Tel
- 18986259541 18986259541
- Fax
- 027-87840182
- sales@3stc.com
- Country
- China
- ProdList
- 4003
- Advantage
- 58
View Lastest Price from (S)-Flurbiprofen manufacturers
- Product
- (S)-Flurbiprofen 51543-39-6
- Price
- US $0.00-0.00/KG
- Min. Order
- 1KG
- Purity
- 98.0%
- Supply Ability
- 10000KGS
- Release date
- 2024-11-19
- Product
- (S)-Flurbiprofen 51543-39-6
- Price
- US $0.00-0.00/mg
- Min. Order
- 10mg
- Purity
- 0.98
- Supply Ability
- 10g
- Release date
- 2024-05-09
- Product
- (S)-Flurbiprofen 51543-39-6
- Price
- US $1.10/g
- Min. Order
- 1g
- Purity
- 99.9%
- Supply Ability
- 100 Tons Min
- Release date
- 2021-06-15